Purpose: The aim of this study was to examine the association between transient interface fluid (TIF) and textural interface opacity (TIO) after Descemet stripping automated endothelial keratoplasty (DSAEK) surgery using intraoperative optical coherence tomography (iOCT) in the PIONEER (Prospective Intraoperative and Perioperative Ophthalmic ImagiNg with Optical CoherEncE TomogRaphy) study.
O ver the past decade, Descemet stripping automated endothelial keratoplasty (DSAEK) has become the most widely performed procedure for the management of corneal endothelial dysfunction. 1 The advantages of DSAEK over traditional penetrating keratoplasty (PK) have been well described. 2 There are, however, postoperative challenges that are more specific to endothelial keratoplasty surgery, including graft dislocation, "air bubble" management issues, and interface complications.
Interface complications are of particular interest because of their myriad etiologies. Although the mechanism for many interface complications, such as infection, epithelial downgrowth, and interface hemorrhage, is usually apparent, some mystery has remained about the phenomenon of "interface haze." Interface haze refers to the typically early presence of a diffuse, central, often undulating, architectural pattern of grayish opacities at the level of the graft-host junction. This type of haze has been variably described as "interface wave-like deposits," 3 "reticular haze," 4, 5 "ground glass interface haze," 6 and most recently "textural interface opacity" (TIO). 7 In keeping with the largest study attempting to classify the condition, we have elected to refer to this phenomenon as TIO.
Several etiologies for TIO have been proposed, most commonly mechanical irregularity induced by the microkeratome blade or the presence of persistent interface fluid or viscoelastic. 7 Although multiple authors have reported TIO developing in the setting of persistent interface separation, [3] [4] [5] 7 confounding the latter theory is the observation that TIO occurs frequently in eyes in which there is no identifiable postoperative interface fluid.
We hypothesize that the presence of occult, intraoperative transient interface fluid (TIF) may account for such cases in which TIO develops in the absence of identifiable postoperative interface fluid. Using the results of intraoperative optical coherence tomography (iOCT), we present new information on the relationship between interface fluid and postoperative TIO.
METHODS
The PIONEER study is a prospective intraoperative and perioperative OCT study initiated at the Cleveland Clinic in November of 2011. All patients were consented, and the study was approved by the institutional review board at the Cleveland Clinic and is adherent to the principles that were established in the Declaration of Helsinki. For this report, we considered all eyes from the PIONEER study that underwent DSAEK by a single surgeon (J.M.G.) between November 2011 and October 2013. There were no exclusion criteria for the use of iOCT.
The same surgical technique was used for all patients. 8 In brief, a temporal, 5-mm scleral tunnel incision was used, and the anterior chamber was maintained with sodium hyaluronate (Healon; Abbott Medical Optics) during Descemet membrane stripping. The peripheral host stroma was roughened with a Terry scraper (Storz). The viscoelastic was removed with single port irrigation and aspiration. All donor tissue was precut by the surgeon's eye bank. Before folding, a thin bead of sodium hyaluronate was injected onto the endothelial surface of all donor tissue. Noncoapting forceps were used for donor insertion. Corneal vent incisions were not created except in rare circumstances (see "Results").
A portable spectral domain OCT system (Envisu C2200; Bioptigen, Research Triangle Park, NC) with customized microscope mount was used for intraoperative imaging. A standard imaging protocol using a 12-· 12-mm cube was used in all cases. iOCT images were routinely obtained after the donor tissue was thought to be completely apposed with a full anterior chamber air fill. Based on the OCT appearance, if the surgeon felt that additional external manipulations were indicated, the OCT was repeated at the conclusion of these maneuvers and before starting the 10-minute "wait period." After performing a complete air-fluid exchange and before patching the eye closed, the iOCT was repeated. One day postoperative OCT (RTVue version 6.8.0.27; Optovue, Inc, Fremont, CA), images were routinely obtained.
Patient demographics including patient age, ocular comorbidities, and previous ocular surgeries were recorded. Donor tissue parameters including preoperative graft thickness and endothelial cell density were logged. Clinical outcome data collected included any clinician documentation of "interface haze," defined as a diffuse, central, undulating, architectural pattern of grayish opacities at the level of the graft-host junction. The postoperative interval at which the haze was first noted and the occurrence of any postoperative complications were also recorded. iOCT and postoperative OCT images were evaluated for the presence of interface fluid. Slit-lamp photographs were taken for demonstrative cases but were not routinely performed. The Student t-test was used to compare continuous variables, and the x 2 test was used to compare categorical variables. Odds ratios were also calculated (GraphPad InStat Version 3.10; GraphPad Software, Inc, San Diego, CA).
RESULTS
Seventy-six eyes from 69 patients were included in this study. Our patient population included 28 men (41%) and 41 women (59%). The mean age at the time of surgery was 71 years, and ranged from 31 to 90. The 2 most common indications for surgery were Fuchs dystrophy (n = 48; 63%) and pseudophakic bullous keratopathy (n = 18; 24%). Six patients (8%) underwent a previously failed PK. Other etiologies for endothelial failure included toxic anterior segment syndrome (n = 1), posterior polymorphous corneal dystrophy (n = 1), aphakic bullous keratopathy (n = 1), and herpetic endotheliitis (n = 1). Forty-nine (64%) eyes were pseudophakic at the time of surgery, 27 (36%) were phakic, and 1 eye was aphakic. Four eyes had previous glaucoma surgery. Seven eyes were functionally unicameral (prior vitrectomy with open posterior capsule). All patients had a minimum of 1-month follow-up.
All corneal grafts were precut by the surgeon's eye bank. Graft size varied from 7.5 to 8.0 mm. The mean preoperative graft thickness for all donor tissue was 129 6 34 mm as reported by the eye bank. There was no significant difference in graft thickness in eyes with TIF (133 mm) and those without TIF (128 mm) (P = 0.58). There was also no significant difference in graft thickness in those eyes with TIO (136 mm) and without postoperative TIO (127 mm) (P = 0.71). There was also no significant difference in donor endothelial cell counts between eyes with TIF and those without (P = 0.74).
Forty-nine (64.5%) eyes underwent only DSAEK, 24 (31.6%) underwent combined DSAEK and cataract extraction, 1 underwent DSAEK with scleral-sutured intraocular lens, and 1 underwent DSAEK with an iris-sutured intraocular lens. Three eyes underwent phakic DSAEK surgery. Corneal vent incisions were performed in 2 cases (2.6%). In both these cases, venting incisions were performed based on the identification of significant central interface fluid after routine corneal sweeping. In both cases, the vent was manually gaped with a Sinskey hook while the cornea was externally swept toward the incision. In both cases, the interface gap did not resolve, and no future venting incisions were attempted, regardless of interface appearance on iOCT. Table 1 summarizes all cases of patients with TIF or TIO. In 58 (76.3%) eyes, no interface fluid was visible on iOCT at the end of surgery after air-fluid exchange. In 18 (23.7%) eyes, TIF was visible on iOCT. TIO was documented in 18 (23.7%) eyes in the postoperative period. Of the 18 patients with TIO, 14 (77.8%) had TIF on iOCT at the conclusion of the surgery. Figure 1 summarizes the distribution of cases with TIO and TIF. TIF on iOCT was associated with a higher rate of postoperative TIO (odds ratio = 47.25; P , 0.0001).
Of the 18 eyes with TIF, 14 developed TIO. In the 4 eyes that did not develop TIO, 2 experienced graft dislocation on the first postoperative day (POD) and were successfully rebubbled. In both these cases, there was no TIF visible on iOCT when the graft was reattached. Only 2 of the 18 eyes (11.1%) that had TIF on iOCT had persistence of the fluid on the first POD OCT. One of these eyes had resolution of the interface gap by the seventh POD, whereas the other continued to have slight persistence of the interface gap 3 months after surgery. The overall graft dislocation rate in all eyes was 7.9%.
DISCUSSION
The use of iOCT to visualize the DSAEK graft-host interface was first described in 2010 by Knecht et al. 9 These authors reported 2 cases in which occult central donor-host interface separation was identifiable on iOCT. Interestingly, both these grafts were completely attached on the first POD, indicating that complete intraoperative donor-host graft apposition was not required for subsequent graft adherence. Some authors have reported the resolution of intraoperative gap with interventions such as the creation of venting incisions 9,10 or additional aspiration. 11 In other patients, the effect of venting incisions on intraoperative gap was more limited. 9 Anshu et al 4 reported a case of persistent interface fluid at the 1-month postoperative visit in which a drainage incision was created with a diamond blade, but the interface gap persisted.
In this large prospective consecutive case series, we demonstrate a strong correlation between the presence of central TIF and the appearance of postoperative TIO. Eyes with TIF had a statistically significantly increased risk of developing TIO. Of the 4 patients in whom TIF was present but TIO did not develop, 2 had graft dislocations on POD 1 and therefore did not have any "resolution" of the TIF. It is not clear as to why TIO was not visible in the other 2 cases, but it is possible that TIO was present but not documented.
Also worth discussing are the 4 cases in which a "haze" was documented despite the absence of initial TIF. In 3 of these cases, the interface haze was noted later in the postoperative period than in the typical 30 days seen with TIO and may have represented other forms of interface haze. In 1 case, "peripheral haze" was documented in the same location as a resolved fluid cleft. Two of the patients in this group had "trace haze" documented in the setting of unexplained decreased vision. This may reflect observer bias related to the decreased visual acuity. The last case was also documented as "trace haze" and only noted approximately 10 months after the surgery. We believe these 4 cases are likely false positives, but chose to include them to be as rigorous as possible with our data analysis.
The composition of TIF is likely a variable mixture of aqueous, balanced salt solution, and, in some cases, viscoelastic. Slowly resolving TIF, especially that which requires weeks or longer to resolve, may represent viscoelastic or a viscoelastic-aqueous mixture (Figs. 2, 3 ). Fast resolving TIF (not visible clinically or by OCT on the first postoperative examination) may represent aqueous or balanced salt solution fluid pockets (Fig. 4) . The fact that both slow and fast resolving TIFs are associated with TIO indicates that retained viscoelastic may not be the sole etiology of TIO. The presence of TIF did not seem to impact the likelihood of postoperative donor adherence. Most grafts with an intraoperative interface gap had a complete resolution of the interface fluid and were fully attached on the first POD (77.8%). Although a higher percentage of these eyes had graft dislocations than did eyes without TIF (11.1% vs. 6.9%), this finding was not statistically significant. It is interesting to note that removing small amounts of TIF with external measures proved to be extremely difficult. We observed that if initial corneal sweeps were performed with a high-pressure air fill in the anterior chamber, further interventions, such as repeated sweeping, increased time with air fill, or placement of corneal venting incisions, did not result in an improvement or closure of the gap. It is also interesting to note that some eyes develop TIF, whereas others do not. Based on the parameters that we studied, we could not identify any preoperative risk factors to explain why TIF occurs. One hypothesis has suggested that thinner graft tissue would result in smaller or no TIF. 9 However, in our sample, graft thickness was not significantly different in eyes with an interface gap compared with those without an interface gap. Mean graft size and donor endothelial cell counts were also not significantly different in the 2 groups. Graft insertion technique has also been identified as a possible risk factor. We used only 1 graft insertion technique in our study, but previous authors have reported cases of TIO with a variety of insertion styles and insertion devices. 7 Other parameters, such as postcut donor-host curvature mismatch, may play a role, but evaluating this theory is technically difficult.
Based on the results of this study, we suggest that the classic "wave-like" interface haze, or TIO, occurs preferentially in eyes in which a central, loculated pocket of interface fluid forms during surgery. The mechanism by which this pocket of fluid forms is not clear. It has been hypothesized that the separation between donor and host corneas may be caused by microkeratome-induced fibrillar irregularities extending from the donor surface. Newman et al 12 showed using electron microscopy that an eye with TIO had irregular collagen fibrils of varying lengths at the stromal surface of the donor tissue. In this study, the height of sequestered fluid was often in great excess of the OCTobservable irregularities in the donor tissue; however, it is possible that very fine fibrils may not be visible on iOCT.
Although irregularities in donor tissue may play a role in the actual pattern of TIO, it seems unlikely that it is solely responsible for TIF formation. Alternatively, curvature mismatch between the donor lenticule and host stroma may preclude immediate, complete central apposition at the time of surgery. As the sequestered fluid traverses the donor tissue, interface opacity may result from residual solutes or decomposition products are concentrated or precipitated on the donor stromal surface.
Hyperreflectivity on donor surface is visible before complete resolution of the interface gap (Fig. 2 ). Whether this hyperreflectivity represents the simple apposition of 2 tissue planes, inherent irregularities of the donor surface, abnormalities in tissue hydration, or early deposition of concentrated solutes is unclear. We favor the latter explanation based on the observation that the prominent hyperreflectivity seen postoperatively was not visualized on iOCT at the time of graft insertion. The resulting wavy or reticular pattern of deposits may be related to the undulating surface contour of the donor lenticules ( Fig. 3) . Perhaps the most important observation of our study is that that some degree of TIO developed even in cases in which the interface gap completely resolved by the first POD. This finding was of particular importance because it may explain the majority of "idiopathic" TIO cases reported before the availability of iOCT.
Although this study reflects the results from a prospective iOCT study, assessment of TIO was not evaluated in a prospective fashion. This limits our ability to compare the severity of TIO and its relationship to the amount of TIF in an objective fashion. Given the retrospective analysis, we did not systematically grade TIO severity and acknowledge that there may have been differences in sensitivity of the observer in documenting interface haze. Also not addressed by our study is the impact of interface haze on best-corrected visual acuity postoperatively. For this report, we have focused on the anatomic abnormality of TIO and the factors associated with its formation. For future studies, we expect to be able to provide a longer follow-up and the long-term implications for visual acuity.
In summary, this report strongly supports the role of TIF in the development of postoperative TIO. This represents one of the first applications of iOCT to improve the understanding of the pathogenesis of a postoperative abnormality in DSAEK surgery. We are currently in the process of developing a masked, prospective trial to confirm or refute this hypothesis.
